Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Evaluation of HEMOBLAST™ Bellows Performance and Safety in Spine Surgery

NCT04471350 is registered in ClinicalTrials.gov with Biom'Up France SAS as lead sponsor.

NCT NCT04471350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04471350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Evaluation of HEMOBLAST™ Bellows Performance and Safety in Spine Surgery
Lead sponsor
Biom'Up France SAS
Phase
Observational
Overall status
Withdrawn
Start date
June 30, 2021
Completion date
August 31, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis